Skip to content

Prevalence Rate, and Clinical Characteristics of Obesity Hypoventilation Syndrome Via Screening Patients Admitted to Medical Intensive Care Units

Prevalence Rate, and Clinical Characteristics of Obesity Hypoventilation Syndrome Via Screening Patients Admitted to Medical Intensive Care Units

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02934581
Enrollment
52
Registered
2016-10-17
Start date
2014-10-29
Completion date
2018-10-31
Last updated
2021-03-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity Hypoventilation Syndrome

Brief summary

A prospective observation study to screen adult obese (BMI ≥30 kg/m2) patients who were newly admitted to the medical intensive care units and turned out to be diagnosed as Obesity hypoventilation syndrome(OHS). The investigators purpose is to look into the prevalence, predictive factors, and outcomes of OHS in these critically ill patients.

Interventions

None listed

Sponsors

National Taiwan University Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
20 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* BMI ≥ 30 kg/m2 * Suspected chronic hypercapnia as following Paco2 ≥ 45 mmHg, HCO3- ≥ 27mEq/L or base excess, BE ≥ 2 mEq/L

Exclusion criteria

* Malignancy with lung involvement * Autoimmune disease with lung involvement * Moderate to severe obstructive respiratory pattern via spirometry * Uncontrolled endocrine disease * Pregnancy * Pneumonia confirmed by image * Out-of-hospital cardiac arrest * Lung edema * Foreigner of Taiwan

Design outcomes

Primary

MeasureTime frameDescription
Prevalence of obesity hypoventilation syndrome in Asian critically ill patients2-yearDetecting obesity hypoventilation syndrome via screening obesity(BMI\>=30kg/m\^2) in critical care units in Asian.

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026